CS Diagnostics Corp.
CSDX
$0.10
$0.0226.16%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -507.79% | 3,200.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 375.32% | 3,200.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 375.32% | 3,200.00% | |||
| SG&A Expenses | 204.74% | 4,540.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 204.74% | 4,540.00% | |||
| Operating Income | 19,650.00% | -200.00% | |||
| Income Before Tax | 19,650.00% | -200.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19,650.00% | -200.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19,650.00% | -200.00% | |||
| EBIT | 19,650.00% | -200.00% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 327.62% | 0.00% | |||
| Average Diluted Shares Outstanding | 327.62% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||